Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-046680
Filing Date
2021-12-02
Accepted
2021-12-02 21:44:11
Documents
1
Period of Report
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5406
  Complete submission text file 0000899243-21-046680.txt   6920
Mailing Address BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 211468558

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations